Aequus Pharmaceuticals Inc.

Ordinary Shares International Reporting
Verified Company Profile 6/06/2017
Contact Info
  • Suite 2820
  • 200 Granville Street
  • Vancouver, BC V6C 1S4
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Quarterly Report
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2000 - Food and Kindred Products
Incorporated In: British Columbia, Canada
Year of Inc. 2013
Employees 8 a/o Jul 15, 2015
Company Officers/Contacts
Doug Janzen CEO
Anne Michelle Stevens COO, Corporate Secretary
Ann Fehr CFO
Ian Ball CCO
Dr. Donald McAfee Chief Scientific Officer
Hanspaul Pannu Controller
Company Directors
Doug Janzen Chairman
Christopher J. Clark
Jason G. Flowerday
Fotios Plakogiannis
Rodoula Plakogiannis
Hamed Shahbazi
Anne Michelle Stevens
Service Providers
Accounting/Auditing Firm
Crowe MacKay LLP
1100 - 1177 West Hastings Street
Vancouver, BC, V6E 4T5
Securities Counsel
Blake, Cassels and Graydon LLP
595 Burrard St.
Suite 2600
Vancouver, BC, V7X 1L3
Investor Relations Firm
Brisco Capital
505 8th Avenue S.W.
Calgary, ALB, T2P1G2
AQSZF Security Details
Share Structure
Market Value1 $9,825,052 a/o Oct 20, 2017
Authorized Shares Unlimited a/o May 31, 2017
Outstanding Shares 71,351,138 a/o Aug 29, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 54,951,694 a/o May 31, 2017
Par Value Not Available
Transfer Agent(s)
Shareholders of Record 64 a/o May 31, 2017
Non US Stock Exchange Listing
AQS - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 33,475 (223.12%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security